Large Cap Biopharmaceuticals: Provide Growth, Value and Yield…Update-3
May 25 -Update-3 ..We will take this little rally after all the turmoil recently. Our Strategy has not changed since January which is to stay with large cap biopharma stocks . We would like to pick some winners among the smaller cap biotech and diagnostics stocks but it has been difficult....
Hiding from Volatility with Healthcare Stocks…Update2- oversold rally time!
Update-2 …5/13 Many analysts see today’s sharp upside action as an oversold rally from 2022 lows.The highest risk stocks soared along with large cap tech stocks. NASDAQ was up 3.75%,S&P up 2.3%, DOW up 1.42%. To some extent this shifted action away from more defensive healthcare...
How is it going with the Big Biopharma Earnings Week?…Update-5…a wild volatile week!
Update -5 …5/6 A wild volatile week catalyzed by FED policy statements. We won’t go into the debate over FED communications about rate hikes and just say that rising rates are a headwind for equities and curb speculation. With higher rates small cap growth has a higher bar of...
Risky Trading Days Lie Ahead, Can Earnings Support the Bulls? Update-4…. broad sell-off
4/26 The constellation of bad news is overwhelming the market: China lock-down, War in Ukraine, commodity prices and WTI up and a horrible tape. MSFT earnings should help us tomorrow but we are in a bear mindset. IBB down 3.86% to $119.39 a 52 week low and the XBI down 5.98% to $76.69 at...
Healthcare Stocks Lead the Way Up as the Market Fades…Update-2 rally day
Update-2 4/13 11;36 AM EDT.…GSK buys Sierra Oncology (SRRA) for $1.9B https://www.bizjournals.com/sanjose/news/2022/04/13/glaxosmithkline-to-buy-sierra-oncology-for-19b.html?ana=yahoo XBI up 2.48% to $89 handle, ARKG up 2.35%. Large caps lag except REGN up. ABBV down over 5%! Green tape...